Real-time enrollment status for this glioma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 2:47 AM UTC
| NCT Number | NCT06161519 |
| Recruiting Status | Recruiting |
| Condition | Glioma |
| Phase | PHASE1 |
| Target Enrollment | 146 participants |
| Active Locations | 1 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | May 13, 2026 (May 13, 2026) |
As of July 17, 2026: Clinical trial NCT06161519 is currently recruiting participants. This phase1 study for glioma is actively seeking new participants at 1 location across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06161519 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06161519 was last updated May 13, 2026 (May 13, 2026). HelloStudys verifies this status automatically.